Biblio
3D Bioprinting of Organoids: past, present, and prospective. Tissue Eng Part A. 2024.
. . Comparison of extruded cell nanovesicles and exosomes in their molecular cargos and regenerative potentials. Nano Res. 2023;16(5):7248-7259.
. . Engineering stem cell therapeutics for cardiac repair. J Mol Cell Cardiol. 2022;171:56-68.
. Cardiac fibrosis: myofibroblast-mediated pathological regulation and drug delivery strategies. Adv Drug Deliv Rev. 2021.
. Extruded Mesenchymal Stem Cell Nanovesicles Are Equally Potent to Natural Extracellular Vesicles in Cardiac Repair. ACS Appl Mater Interfaces. 2021.
. A pre-investigational new drug study of lung spheroid cell therapy for treating pulmonary fibrosis. Stem Cells Transl Med. 2020.
. . .
Human Cardiosphere-Derived Cells From Advanced Heart Failure Patients Exhibit Augmented Functional Potency in Myocardial Repair. JACC Heart Fail. 2014;2(1):49-61.